Cargando…
Use of MRI, metabolomic, and genomic biomarkers to identify mechanisms of chemoresistance in glioma
Gliomas are the most common form of central nervous system tumor. The most prevalent form, glioblastoma multiforme, is also the most deadly with mean survival times that are less than 15 months. Therapies are severely limited by the ability of these tumors to develop resistance to both radiation and...
Autores principales: | Levenson, Cathy W., Morgan, Thomas J., Twigg, Pamela D., Logan, Timothy M., Schepkin, Victor D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992521/ https://www.ncbi.nlm.nih.gov/pubmed/35582585 http://dx.doi.org/10.20517/cdr.2019.18 |
Ejemplares similares
-
Proteomic Analysis of Glioma Chemoresistance
por: Suk, Kyoungho
Publicado: (2012) -
Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
por: McEvoy, Lynda M., et al.
Publicado: (2015) -
$\nu \to P+\gamma$ decays in the bag model
por: Schepkin, M
Publicado: (1978) -
Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine
por: Guo, Chong, et al.
Publicado: (2020) -
The Effect of Polysialic Acid Expression on Glioma Cell Nano-mechanics
por: Grant, Colin A., et al.
Publicado: (2016)